| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $151.1M | — | +51.4% |
| Cost of Revenue | $107.2M | — | +54.7% |
| Gross Profit | $43.9M | — | +43.8% |
| R&D Expense | $25.7M | — | +44.1% |
| SG&A Expense | $24.9M | — | +52.7% |
| Operating Income | -$13.0M | — | -45.4% |
| Pre-tax Income | -$13.2M | — | -44.3% |
| Income Tax | $1.0M | — | — |
| Net Income | -$14.3M | — | -55.7% |
| EPS (Basic) | -$0.19 | — | -5.6% |
| EPS (Diluted) | -$0.19 | — | -5.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $439.7M | +113.3% | +759.7% |
| Accounts Receivable | $299.0M | +22.3% | +74.7% |
| Inventory | $206.2M | +12.6% | +101.6% |
| Current Assets | $992.6M | +46.9% | +176.6% |
| Total Assets | $1.57B | +34.0% | +142.9% |
| Current Liabilities | $259.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$85.4M | — | -67.6% |
| Capital Expenditures | $58.2M | — | +105.1% |
| Investing Cash Flow | -$68.1M | — | -87.6% |
| Financing Cash Flow | $389.3M | — | +456.0% |
| Free Cash Flow | -$143.6M | — | -81.0% |
| +35.8% |
| Long-term Debt | $0 | -100.0% | -100.0% |
| Total Liabilities | $459.9M | +5.9% | +37.0% |
| Stockholders' Equity | $1.11B | +50.7% | +257.9% |